These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 29892286)

  • 1. Insight Into Non-Pathogenic Th17 Cells in Autoimmune Diseases.
    Wu X; Tian J; Wang S
    Front Immunol; 2018; 9():1112. PubMed ID: 29892286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenicity of Th17 cells in autoimmune diseases.
    Yasuda K; Takeuchi Y; Hirota K
    Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.
    Yan L; Hu F; Yan X; Wei Y; Ma W; Wang Y; Lu S; Wang Z
    J Mol Med (Berl); 2016 Sep; 94(9):1063-79. PubMed ID: 27052830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
    Hu Y; Shen F; Crellin NK; Ouyang W
    Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular control of pathogenic Th17 cells in autoimmune diseases.
    Wu B; Wan Y
    Int Immunopharmacol; 2020 Mar; 80():106187. PubMed ID: 31931372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected.
    Brinkhoff A; Sieberichs A; Engler H; Dolff S; Benson S; Korth J; Schedlowski M; Kribben A; Witzke O; Wilde B
    Front Immunol; 2018; 9():1133. PubMed ID: 29868038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
    Stadhouders R; Lubberts E; Hendriks RW
    J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.
    Matsuzaki G; Umemura M
    Microbiol Immunol; 2018 Jan; 62(1):1-13. PubMed ID: 29205464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity.
    Chen Y; Chauhan SK; Tan X; Dana R
    J Autoimmun; 2017 Feb; 77():96-103. PubMed ID: 27899224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
    Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
    Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
    Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
    BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
    Maddur MS; Miossec P; Kaveri SV; Bayry J
    Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
    Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
    J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Interleukin-17 Production.
    Dong W; Ma X
    Adv Exp Med Biol; 2016; 941():139-166. PubMed ID: 27734412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 cell pathogenicity and plasticity in rheumatoid arthritis.
    Yang P; Qian FY; Zhang MF; Xu AL; Wang X; Jiang BP; Zhou LL
    J Leukoc Biol; 2019 Dec; 106(6):1233-1240. PubMed ID: 31497905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.